| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/10/2003 | WO2002041889A3 Indolsulfonyl compounds useful in the treatment of cns disorders |
| 04/10/2003 | WO2001083800A3 Heterologous production of polyketides |
| 04/10/2003 | US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects |
| 04/10/2003 | US20030069297 4-aryl substituted indolinones |
| 04/10/2003 | US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 04/10/2003 | US20030069277 Anticancer agents |
| 04/10/2003 | US20030069276 Viricides; aids therapy |
| 04/10/2003 | US20030069275 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 04/10/2003 | US20030069261 Therapy for eating disorders, sexual disorders, psychological disorders |
| 04/10/2003 | US20030069257 Benzimidazole and pyridylimidazole derivatives |
| 04/10/2003 | US20030069245 Aids therapy |
| 04/10/2003 | US20030069239 Anticancer agents |
| 04/10/2003 | US20030069238 Anticancer agents; immunology diseases; antiallergens; antiinflammatory agents |
| 04/10/2003 | US20030069230 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists |
| 04/10/2003 | US20030069224 Non-nucleoside reverse transcriptase inhibitors |
| 04/10/2003 | US20030069223 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium |
| 04/10/2003 | US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses. |
| 04/10/2003 | US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives |
| 04/10/2003 | US20030069140 Herbicides |
| 04/10/2003 | US20030066988 Electroconductivity coloring |
| 04/10/2003 | CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462142A1 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system |
| 04/10/2003 | CA2461919A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 04/10/2003 | CA2461381A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | CA2460909A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
| 04/10/2003 | CA2460594A1 Mch receptor antagonists |
| 04/10/2003 | CA2460168A1 4¬piperidin-4-yliden-(3-carbamoylphenyl)methyl| benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/10/2003 | CA2457647A1 Benzimidazolidinone derivatives as muscarinic agents |
| 04/09/2003 | EP1300401A1 Five-membered-ring compound |
| 04/09/2003 | EP1300399A1 Phenylpyridazine derivatives and drugs containing the same |
| 04/09/2003 | EP1300398A1 Propane-1,3-dione derivatives |
| 04/09/2003 | EP1300396A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 04/09/2003 | EP1299384A1 Indole derivatives useful for the treatment of cns disorders |
| 04/09/2003 | EP1299382A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 04/09/2003 | EP1299381A1 Substituted quinazoline derivatives and their use as inhibitors |
| 04/09/2003 | EP1299378A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 04/09/2003 | EP1299365A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 04/09/2003 | EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 04/09/2003 | EP1299361A1 Pyrazole derivatives |
| 04/09/2003 | EP1299356A1 Novel compounds |
| 04/09/2003 | EP0946528B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 04/09/2003 | EP0904273B1 Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist |
| 04/09/2003 | EP0873123B1 Inhibitors of protein isoprenyl transferases |
| 04/09/2003 | EP0850224B1 Radiation-activated cytotoxin therapy |
| 04/09/2003 | EP0843663B1 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases |
| 04/09/2003 | EP0758327B1 Pyranone compounds useful to treat retroviral infections |
| 04/09/2003 | CN1409708A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 04/09/2003 | CN1409703A 4-aminopiperidine derivatives and their use as medicine |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/08/2003 | US6545158 Such as N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5-hydroxyindol-3-yl)-2 -oxoacetamide; for treatment of eosinophil-related disorders and chronic obstructive pulmonary disease |
| 04/08/2003 | US6545150 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6545037 Thromboxane A2 (TXA2) receptor and 5HT2 serotonergic receptor antagonists; 3-(6-(((4-chlorophenyl)sulphonyl)amino)-3-((2-(4-methyl-1 -piperazinyl)phenoxy)methyl)-5,6, 7,8-tetrahydro-1-naphthyl)propanoic acid for example |
| 04/08/2003 | US6545025 Antiinflammatroy agents; antiallergens |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/08/2003 | US6545009 Retinoid-related receptor function regulating agent |
| 04/08/2003 | US6544997 E.g., hypermotility, irritable bowel syndrome, bowel hypersensitivity and the reduction of pain associated with gastrointestinal hypersensitivity and/or hyperactivity |
| 04/08/2003 | US6544995 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein |
| 04/08/2003 | US6544990 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors |
| 04/08/2003 | US6544989 Fungicidal, insecticidal, acaricidal, molluscicidal or nematicidal composition |
| 04/08/2003 | US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 04/08/2003 | US6544986 Such as 5-(N,N-dibenzyl)aminocarbonyl-2-pyridone; enzyme inhibitors; for treatment of Alzheimer's disease |
| 04/08/2003 | US6544985 For therapy of acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits |
| 04/08/2003 | US6544982 3-aryl-5-aminoisoxazole derivatives |
| 04/08/2003 | US6544981 Anticoagulants, cardiovascular disorders |
| 04/08/2003 | CA2252898C Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one(=ziprasidone), its preparation and its use as dopamine d2 antagonist |
| 04/08/2003 | CA2224983C Triazole antifungal agents |
| 04/03/2003 | WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | WO2003027234A2 Small organic molecule regulators of cell proliferation |
| 04/03/2003 | WO2003027108A1 Heterocyclic derivatives and their use as hypoglycaemic and hypolipidemic agents |
| 04/03/2003 | WO2003027107A1 Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027105A1 Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 04/03/2003 | WO2003027101A1 Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027100A1 Substituted 3-pyridyl pyrimidines as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027096A1 Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027095A1 Substituted 3-pyridyl tetrazoles as steroid c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027094A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027090A2 Bicyclic heterocycles as rxr ligands |
| 04/03/2003 | WO2003027085A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027081A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 04/03/2003 | WO2003027080A1 3-substituted-4-pyrimidone derivatives |
| 04/03/2003 | WO2003027068A2 Substituted amines for the treatment of neurological disorders |
| 04/03/2003 | WO2003026666A1 2-phenylamino-4- (5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, as src kinase inhibitors |
| 04/03/2003 | WO2003026665A1 2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors |
| 04/03/2003 | WO2003026664A1 2-phenylamino-4- (5-pyrazolylamino) -pyramidine derivatives as kinase inhibitors, in particular, src kinase inhibitors |
| 04/03/2003 | WO2003026586A2 Pioglitazone hydrochloride |
| 04/03/2003 | WO2003011859A3 Oxazolidinone derivatives as antibacterial agents |
| 04/03/2003 | WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | WO2002102313A3 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 04/03/2003 | WO2002074738A3 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 04/03/2003 | US20030065192 Antimicrobial compounds and methods of use |
| 04/03/2003 | US20030065191 Process for the preparation of thiazole derivatives |
| 04/03/2003 | US20030065179 Diabetic therapy |
| 04/03/2003 | US20030065176 Anticoagulant; cardiovascular disorders |
| 04/03/2003 | US20030065175 Novel heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them |
| 04/03/2003 | US20030064996 Anticarcinogenic agents, antiinflammatory agents, anticholesterol agents, antidiabetic agents |
| 04/03/2003 | US20030064985 Prevent virus reproduction |
| 04/03/2003 | US20030064984 Anticancer agents; side effect reduction |